Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation

Benign prostatic hyperplasia (BPH) occurs most commonly among older men, often accompanied by chronic tissue inflammation. Although its aetiology remains unclear, autoimmune dysregulation may contribute to BPH. Regulatory T cells (Tregs) prevent autoimmune responses and maintain immune homeostasis....

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xi, Lin, Tianhai, Yang, Guang, Cai, Huawei, Tang, Bo, Liao, Xinyang, Li, Huifang, Chen, Xiaoting, Gong, Lina, Xu, Hang, Sun, Yi, Tan, Ping, Yin, Jianqiong, Ma, Hongwen, Ai, Jianzhong, Wang, Kunjie, Wei, Qiang, Yang, Lu, Li, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205803/
https://www.ncbi.nlm.nih.gov/pubmed/32191396
http://dx.doi.org/10.1111/jcmm.15137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205803/
https://www.ncbi.nlm.nih.gov/pubmed/32191396
http://dx.doi.org/10.1111/jcmm.15137

Ejemplares similares